Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Sana Biotechnology
SANA
$949M
| $1.2M | ﹤0.01% |
295,100
+100,231
| +51% | +$369K |
|
2277
MillerKnoll
MLKN
$1.61B
| $1.2M | ﹤0.01% |
45,100
-93,083
| -67% | -$2.38M |
|
2278
Forum Energy Technologies
FET
$846M
| $1.2M | ﹤0.01% |
54,200
+2,025
| +4% | +$45.5K |
|
2279
F&G Annuities & Life
FG
$3.87B
| $1.2M | ﹤0.01% |
26,068
-21,932
| -46% | -$818K |
|
2280
Albany International
AIN
$1.74B
| $1.2M | ﹤0.01% |
12,200
-56,200
| -82% | -$4.9M |
|
|
QIPT
2281
DELISTED
Quipt Home Medical
QIPT
| $1.2M | ﹤0.01% |
235,324
+146,724
| +166% | +$703K |
|
2282
Tango Therapeutics
TNGX
$4.72B
| $1.2M | ﹤0.01% |
121,000
+82,800
| +217% | +$719K |
|
2283
Erie Indemnity
ERIE
$13.3B
| $1.2M | ﹤0.01% |
3,571
-85,500
| -96% | -$25.7M |
|
2284
James River Group Holdings
JRVR
$221M
| $1.2M | ﹤0.01% |
129,400
+31,602
| +32% | +$363K |
|
2285
Direxion Daily Small Cap Bear 3x ETF
TZA
$217M
| $1.19M | ﹤0.01% |
+5,980
| New | +$1.79M |
|
2286
Oxford Industries
OXM
$560M
| $1.19M | ﹤0.01% |
11,921
-14,600
| -55% | -$1.36M |
|
|
YMAB
2287
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.19M | ﹤0.01% |
174,800
-62,290
| -26% | -$360K |
|
2288
Dimensional International Small Cap Value ETF
DISV
$5.07B
| $1.19M | ﹤0.01% |
+46,200
| New | +$1.11M |
|
2289
Dimensional US Core Equity Market ETF
DFAU
$12.8B
| $1.19M | ﹤0.01% |
35,800
+17,000
| +90% | +$528K |
|
2290
LGL Group
LGL
$48.1M
| $1.19M | ﹤0.01% |
193,734
+1,500
| +0.8% | +$7.33K |
|
2291
Nurix Therapeutics
NRIX
$2.62B
| $1.19M | ﹤0.01% |
115,200
+88,400
| +330% | +$606K |
|
|
DOYU
2292
DouYu International Holdings
DOYU
$137M
| $1.19M | ﹤0.01% |
124,950
-650
| -0.5% | -$5.61K |
|
2293
MannKind Corp
MNKD
$1.24B
| $1.19M | ﹤0.01% |
326,045
-151,600
| -32% | -$579K |
|
2294
iShares ESG Optimized MSCI USA ETF
SUSA
$4.15B
| $1.19M | ﹤0.01% |
11,800
+4,200
| +55% | +$392K |
|
2295
Protalix BioTherapeutics
PLX
$197M
| $1.19M | ﹤0.01% |
665,600
+44,500
| +7% | +$69.2K |
|
|
ATSG
2296
DELISTED
Air Transport Services Group
ATSG
| $1.19M | ﹤0.01% |
67,300
-48,300
| -42% | -$859K |
|
2297
Schwab 1000 Index ETF
SCHK
$5.88B
| $1.18M | ﹤0.01% |
51,400
+21,800
| +74% | +$468K |
|
2298
APi Group
APG
$17.8B
| $1.18M | ﹤0.01% |
51,300
-446,550
| -90% | -$8.61M |
|
2299
Colony Bankcorp
CBAN
$468M
| $1.18M | ﹤0.01% |
88,978
+2,200
| +3% | +$23.8K |
|
|
CTV
2300
DELISTED
Innovid Corp.
CTV
| $1.18M | ﹤0.01% |
787,081
-4,831
| -0.6% | -$6.16K |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.